Bioequivalence Study of Revolade® Eltrombopag 50 mg
Bioequivalence Study of Revolade® Eltrombopag 50 mg
Active, not recruiting · NCT06834451 · Registry updated 2025-06-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Revolade® Eltrombopag 50 mg | Healthy; Healthy Donors | Active, not recruiting | Phase 4 | 2025-06-19 | NCT06834451 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centro de Atencion e Investigacion Medica | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centro de Atención e Investigación Médica | Chía | Colombia | 1 |